Apimeds Pharmaceuticals US (APUS) vs Azitra (AZTR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Apimeds Pharmaceuticals US is the larger company by market cap ($8.3 million vs $8.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | AZTR |
|---|---|---|
| Share price | $5.51 | $0.132 |
| Market cap | $8.32M | $8.00M |
| 1-day change | -21.84% | 0.00% |
| YTD return | -66.40% | — |
| 1-year return | -70.53% | — |
| EPS (TTM) | $-36.03 | $-0.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $1.09 |
| 52-week low | $1.51 | $0.10 |
| Distance from 52-week high | -90.77% | -87.89% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +407.58% |
| Average volume | 3.66M | 1.70M |
| Shares outstanding | 1.51M | 60.60M |
| Employees | — | 13 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Healthcare · Drug Manufacturers - Specialty & Generic
About Azitra
AZTR stock →Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S.
Healthcare · Biotechnology · 13 employees
APUS vs AZTR FAQ
Which is bigger, Apimeds Pharmaceuticals US or Azitra?
Apimeds Pharmaceuticals US (APUS) is larger, with a market capitalization of $8.32M compared with $8.00M for Azitra (AZTR).
Are Apimeds Pharmaceuticals US and Azitra in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for Apimeds Pharmaceuticals US and Biotechnology for Azitra.